Sg3 Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Sg3 Management, LLC

  • $0
  • Q3 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$595.12 - $698.43 $119,024 - $139,686
-200 Closed
0 $0
Q4 2021

Feb 15, 2022
SELL
$543.48 - $670.97 $163,044 - $201,291
-300 Reduced 60.0%
200 $126,000
Q3 2021

Nov 15, 2021
BUY
$574.03 - $680.96 $114,806 - $136,192
200 Added 66.67%
500 $303,000
Q2 2021

Aug 16, 2021
BUY
$472.8 - $558.54 $141,840 - $167,562
300 New
300 $168,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email